Streptococcus pneumoniae and Staphylococcus aureus are common commensals of the upper respiratory tract in children and adolescents. Understanding the relationship between these two pathogens, including their potential for mutual interference, is needed to evaluate the epidemiology of the diseases they cause, the factors that condition acquisition and carriage, and the impact of related preventative measures. We obtained oropharyngeal and nasal swabs from 497 healthy subjects aged 6-17 years. S. pneumoniae detection and serotyping were performed using a real-time PCR and S. aureus detection was performed using the RIDAGENE MRSA system. We found that 136 (27.3 %) of the children were carriers of both species, 121 (24.3 %) of the children carried S. pneumoniae alone and 128 (25.7 %) of the children carried S. aureus alone. S. aureus carriage was similar between children who carried S. pneumoniae (136/257, 52.9 %, 95 % confidence interval [CI]: 46.8-58.9 %) vs those who did not (128/240, 53.3 %, 95 % CI: 47.0 -59.5 %) and was independent of age and vaccination with 7-valent pneumococcal conjugate vaccine (PCV7). Vaccination with PCV7 did not affect S. aureus carriage [S. pneumoniae: 84/143 (58.7 %, 95 % CI: 50.5 -66.5 %) vaccinated children vs 171/ 351 (48.7 %, 95 % CI: 43.5 -53.9 %) unvaccinated children; S. aureus: 67/143 (46.9 %,.7 %) unvaccinated children]. Pneumococcal serotype also did not appear to affect S. aureus carriage. These findings suggested that the carriage of S. pneumoniae did not affect that of S. aureus in older children and adolescents, regardless of age, PCV7 vaccination and pneumococcal serotype.
INTRODUCTION
Streptococcus pneumoniae and Staphylococcus aureus are common commensals of the upper respiratory tract in children (Simell et al., 2012; Wertheim et al., 2005) . Understanding the relationship between these two pathogens, including their potential for mutual interference, is needed to evaluate the epidemiology of the diseases they cause, the factors that condition acquisition and carriage as well as the impact of related preventative measures, such as pneumococcal conjugate vaccines (PCVs). Several studies have investigated the co-colonization of both healthy and ill children by S. pneumoniae and S. aureus but have reported conflicting results (Cohen et al., 2007; McNally et al., 2006; Quintero et al., 2011; Regev-Yochay et al., 2004) . In general, in healthy subjects pneumococcal colonization seems to negatively influence S. aureus carriage, whereas in children with disease, particularly when associated with severe immunodeficiency, this relationship is no more evident. However, several factors other than host immune characteristics can influence carriage and relationships between bacteria that colonize the pharynx. It has been demonstrated that S. pneumoniae carriage is higher in younger patients and declines with age (Le Polain de Waroux et al., 2014; Kluytmans et al., 1997) , while S. aureus carriage has two major peaks, one in early infancy and one in older children (Kwambana et al., 2011) . Moreover, number of siblings, passive smoking, school attendance and socioeconomic characteristics of the family play a role in this regard (Simell et al., 2012) . Finally, administration of PCVs to infants significantly modifies pneumococcal carriage of vaccinated and unvaccinated infants and toddlers, and in some, even if not in all of the studies, has been demonstrated able to influence S. aureus carriage of these subjects. (DukersMuijrers et al., 2013; Bogaert et al., 2004; Xu et al., 2012) . However, most of the studies that have evaluated carriage of pharyngeal bacterial flora and relationships between S. pneumoniae and S. aureus were carried out in younger children and little is known about the characteristics of carriage of these pathogens in school-age children and adolescents. Moreover, no data are available on the impact of PCVs, given several years before, on S. pneumoniae and S. aureus colonization of these subjects. Finally, it is not known whether the pharyngeal site where respiratory secretions used to evaluate carriage are collected can influence the final results. Usually, S. pneumoniae colonization is identified by nasopharyngeal swab (i.e. the swab is obtained by gently passing through a nostril and collecting the specimen from the nasopharynx -the part of the pharynx covering the roof of the mouth), whereas anterior nares sample collection (collecting the specimen from the nostrils) is used for S. aureus evaluation. However, recent studies seem to suggest that oropharyngeal samples are better for determining S. pneumoniae carrier status in school-age children and adolescents (Principi et al., 2014) and may increase S. aureus identification when coupled with traditional anterior nares samples (Mertz et al., 2009) . In order to increase our knowledge of these unsolved problems, a study was planned to evaluate S. pneumoniae and S. aureus nasoand oropharyngeal colonization in a group of school-age children and adolescents partly vaccinated during infancy with the heptavalent pneumococcal conjugate vaccine (PCV7).
METHODS
Swab collection. The study enrolled healthy children and adolescents (aged 6-17 years) attending mandatory school in Milan (Italy) during the second and third week of December 2013. Subjects who received antibiotics 3 weeks prior to sampling were excluded from the study. Data regarding the medical history of each subject, including vaccination, were collected by means of a questionnaire that was completed by parents/guardians for children ,15 years and by the adolescents themselves for those ¢15 years. Children were considered fully vaccinated against S. pneumoniae if they had received three doses of PCV7 in the first year of life, two doses in the second year or a single dose after the second until the fifth year of age, according to the recommendations of the Italian Ministry of Health (http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua= italiano&id=543). Written informed consent was obtained from the parent(s) or legal guardian(s) of each study participant and from participants older than 8 years. Swabbing was carried out by a group of experienced paediatric nurses supervised by a paediatrician (N.P.) in the medical room of each of the two schools at the end of the teaching period on two consecutive days. One oropharyngeal and nasal swab was obtained and analysed for the presence of both S. pneumoniae and S. aureus. Swabs were obtained using the ESwab kit and a polypropylene screw-cap tube with an internal conical shape filled with 1 ml liquid Amies medium (Copan). The oropharyngeal sampling was carried out using a tongue spatula to press the tongue downward to floor of the mouth and swabbing both the tonsillar arches and the posterior pharynx, without touching the sides of the mouth. The nasal swab was inserted into one of the participant's nostril and rotated for 3 s. All swabs were immediately transported to a central laboratory and processed within 2 h.
S. pneumoniae and S. aureus identification. For S. pneumoniae identification, bacterial genomic DNA was directly extracted from the samples using a NucliSENS easyMAG automated extraction system (BioMeriéux), a 250 ml sample input and a generic protocol, and was tested for the autolysin-A-encoding gene (lytA) and the wzg (cpsA) gene of S. pneumoniae by means of real-time PCR (RT-PCR) as previously described (Principi et al., 2014) . Each sample was tested in triplicate, and was considered positive if at least two of the three tests revealed the presence of both genes. The level of detection of the test was 16 genome copies. All of the positive cases were serotyped using primers and probes designed on the basis of the GenBank database sequences (www.ncbi.nlm.nih.gov) of serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F (i.e . those in the 13-valent pneumococcal conjugate vaccine, PCV13), and synthesized by TIB Molbiol as previously described (Principi et al., 2014) . Analytical specificity was pre-evaluated by means of computer-aided analyses using Primer-BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast) and BLAST (http:// www.ncbi.nlm.nih.gov/BLAST/) software in order to compare the sequences with all of the sequences listed 'bacteria' and 'homo sapiens'. S. aureus was identified using the RIDAGENE MRSA system (R-Biopharm AG, http://www.r-biopharm.com/it/). The RIDAGENE MRSA system is a multiplex real-time PCR for the direct, qualitative detection and differentiation of methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA). An internal control was added to the samples during extraction to determine possible PCR inhibition or DNA extraction failure. After DNA isolation, the mecA/ mecC gene, SCCmec/orfX junction (type I, II, III, IV, V, VI, VII, IX and XI) and the orfX gene were amplified by TaqMan according to the manufacturer's instructions using the Agilent Stratagene Mx3005P real-time PCR platform. The samples were evaluated as follows: negative, no amplification signal but internal control DNA positive; MRSA, positive for mecA/mecC, the SCCmec/orfX junction and orfX; MSSA, positive for both the SCCmec/orfX junction and orfX, or only orfX. The RIDAGENE MRSA system has a limit of detection of ¡5 DNA copies per reaction.
Statistical analysis. A contingency table analysis with the chisquared or Fisher's exact test, as appropriate, was used to compare differences between groups. For an easier evaluation of carriage modifications in the studied population, this was arbitrarily subdivided into three age groups (,10, 10-14 and ¢15 years old). Subgroup analyses were performed based on age and PCV7 vaccination status. All tests were two-sided, and a P-value ,0.05 was considered statistically significant. Data were analysed using SAS, version 9.2 (SAS Institute).
RESULTS
The study enrolled 497 subjects (56.5 % male; median age, 12.5 years). Among those enrolled, 199 (40.0 %) were between 6 and 9 years old, 213 (42.9 %) were between 10 and 14 years old and 85 (17.1 %) were ¢15 years old. The carriage of S. pneumoniae and S. aureus according to age is shown in Table 1 . S. pneumoniae and S. aureus were both identified in 136 (27.3 %) of the children; 121 (24.3 %) of the children had S. pneumoniae alone and 128 (25.7 %) had S. aureus alone. S. pneumoniae was most frequently found among children aged 6-9 years (141/199 children, 70.8 %) compared to those aged 10-14 years (91/213 children, No significant differences in the carriage of S. pneumoniae among children also carrying S. aureus were observed, regardless of age. No significant differences in the carriage of S. pneumoniae and S. aureus were observed between children who were versus children who were not vaccinated with PCV7. *Three subjects were excluded due to missing information on PCV7 status.
42.7 %; P,0.0001 vs those aged 10-14 years) and those aged 15-17 years (25/85 children, 29.4 %; P,0.0001 vs those aged 10-14 years and P50.045 vs those aged 15-17 years). In contrast, the detection of S. aureus was similar among all age groups (6-9 years: 99/199 children, 49.7 %; 10-14 years: 117/213 children, 54.9 %; 15-17 years: 48/85 children, 56.5 %). S. aureus carriage was similar between children who were (136/257, 52.9 %) vs were not (128/240, 53.3 %) carrying S. pneumonia, independent of age. All but three of the identified S. aureus were MSSA. The three MRSA were found in children ¢15 years in association with S. pneumoniae.
The carriage of S. pneumoniae and S. aureus according to PCV7 vaccination status is shown in Table 2 . The detection of S. pneumoniae serotypes included in the 13-valent pneumococcal vaccine (PCV13) and S. aureus was similar between children who were vs were not vaccinated with PCV7 (S. pneumoniae: 84/143 (58.7 %, confidence interval The detection of S. aureus was similar between children who were carrying PCV7 serotypes and children who were not carrying S. pneumoniae (Table 3) . Similarly, the detection of S. aureus was similar between children who were carrying serotypes included in the 13-valent pneumococcal conjugate vaccine (PCV13) and children who were not carrying S. pneumoniae.
DISCUSSION
Colonization rates for both S. pneumoniae and S. aureus found in this study were significantly higher than those reported in other similar epidemiological evaluations (Mertz et al., 2009; Principi et al., 2014) . There are several possible explanations for these differences, e.g. host immune characteristics and the greater sensitivity of the molecular methods used in this study. Our results suggest that the carriage of S. pneumoniae does not affect that of S. aureus in school-age children and adolescents. Moreover, the site used to collect respiratory secretions did not influence the results. Finally, we found that PCV7 vaccination and pneumococcal serotype did not affect the carriage of S. aureus.
Previous studies have shown that S. pneumoniae carriage does not affect S. aureus carriage. However, these studies, which include healthy children (Bogaert et al., 2004; Quintero et al., 2011; Regev-Yochay et al., 2004) as well as patients with HIV infection or recurrent acute otitis media (Cohen et al., 2007; McNally et al., 2006) , enrolled infants and toddlers, i.e. subjects much younger than the participants in this study. Here, we show that S. pneumoniae and S. aureus also do not interact in older children. Older children are more frequently colonized by S. aureus; thus, any possible interference of S. pneumoniae on S. aureus growth would be more easily detected.
Interestingly, the swab site did not appear important in the carriage of either pathogen in older children. We recently reported that oral swabs should be used to evaluate S. pneumoniae carriage in school-age children and adolescents (Principi et al., 2014) . Similarly, oropharyngeal sampling was found to contribute significantly to the detection of S. aureus since some S. aureus only colonize the throats of some subjects (Mertz et al., 2009) . The results of this study suggest that further analyses of the relationship between these two pathogens should consider sampling from both sites.
Some studies have found that younger children who were colonized by primarily PCV7 serotypes were less frequent carriers of S. aureus compared to subjects colonized with other serotypes (Bogaert et al., 2004; Xu et al., 2012) . This suggested that the serotypes included in PCV7 could protect against S. aureus colonization. However, in the first few years after PCV7 introduction, vaccinated children experienced a significant reduction in colonization by PCV7 serotypes (Simell, et al., 2012) . Thus, this correlation was thought to explain why children with a history of recurrent acute otitis media could suffer from new instances of S. aureus-related disease after PCV7 vaccination (Veenhoven et al., 2003) . In this study, we did not observe any correlations between PCV7 serotype and S. aureus carriage. This agrees with a previous study that found that S. aureus colonization did not vary significantly between children who were vs were not vaccinated despite a significantly lower carriage of PCV7 serotypes in vaccinated subjects (Cohen et al., 2007) . Moreover, our results indicate that there is also no association between serotypes included in PCV13 and S. aureus carriage. However, these findings cannot be considered conclusive due to the relatively low number of subjects who were enrolled and the high number of unvaccinated subjects included in the study. Pneumococcal vaccination coverage remained until 2009 no higher than 50 % in some Italian regions, including Lombardy where the study was carried out, because the vaccine was neither given free of charge nor reimbursed. Because indirect effects of PCVs, including reduction of carriage in unvaccinated subjects are evident only when high vaccination coverage occurs (Simell et al., 2012) , it is possible that in the future more significant modification of S. pneumoniae colonization due to increased vaccination coverage might have a significant effect also on S. aureus colonization; in addition, the potential involvement of other bacterial species was not studied.
In conclusion, we did not find an association between the carriage of S. pneumoniae and that of S. aureus in older children and adolescents regardless of age, PCV7 vaccination and pneumococcal serotype. Further studies are needed to evaluate the long-term impact of pneumococcal vaccinations, particularly that of PCV13, on S. aureus carriage.
